ArticleFrontiers in medicine2026
Hypertension among Middle Eastern and North African adults residing in the United States: addressing equity in health research representation using the All of Us Research Program, 2000-2024.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertension (HTN) is a leading modifiable risk factor for cardiovascular disease and mortality; however, its epidemiology among the Middle Eastern and North African (MENA) population residing in the United States (US) remains uncharacterized due to historical racial misclassification and underrepresentation in national datasets. This study aimed to evaluate HTN prevalence, treatment, control, and predictors among MENA adults using data from the All of Us Research Program (2000-2024). Methods: This was a retrospective cohort study of self-identified MENA adults aged ≥18 years with at least one outpatient blood pressure (BP) measurement. HTN was defined by an outpatient diagnosis of essential HTN. BP control was assessed using time in target range among participants with at least two outpatient BP measurements after index date and was defined as BP < 140/90 mm Hg ≥50% of outpatient visits. A stepwise logistic regression model was used to identify significant predictors of HTN. Results: Among 2,572 MENA adults included in the analysis, 18% (463) had HTN. Among hypertensive participants, 76% (352 of 463) received antihypertensive treatment, and 85% (400 of 463) achieved BP control. Participants aged ≤ 50 years demonstrated significantly higher BP control proportion, compared with those aged >50 years (97 vs. 83%, Conclusions: Among US MENA adults that participated in the All of Us research Program, HTN prevalence was lower than estimates reported for the general US adult population, while treatment and BP control were higher. Cardiometabolic conditions were the primary drivers of HTN risk, with additional associations observed for vitamin D deficiency and anemia, highlighting the need for improved inclusion of MENA adults in national health research to inform targeted prevention and management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.